{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/ALXO/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T11:29:34.172Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1957,"canonical_name":"ALX ONCOLOGY HOLDINGS INC","cik":"0001810182","uei":null,"lei":null,"duns":null,"ticker":"ALXO"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":11},"count":11,"timeline":[{"ts":"2026-08-18","kind":"sec.filing","form_type":"4","title":"4 — ALX ONCOLOGY HOLDINGS INC — 2026-08-18","url_slug":"/sec/cik-0001810182/4/0001193125-26-355761","accession_number":"0001193125-26-355761","importance":30},{"ts":"2026-08-14","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — ALX ONCOLOGY HOLDINGS INC — 2026-08-14","url_slug":"/sec/cik-0001810182/schedule-13g-a/0001193125-26-352359","accession_number":"0001193125-26-352359","importance":30},{"ts":"2026-08-06","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ALX ONCOLOGY HOLDINGS INC — 2026-08-06","url_slug":"/sec/cik-0001810182/10-q/0001193125-26-337920","accession_number":"0001193125-26-337920","importance":45},{"ts":"2026-08-06","kind":"sec.filing","form_type":"8-K","title":"8-K — ALX ONCOLOGY HOLDINGS INC — 2026-08-06","url_slug":"/sec/cik-0001810182/8-k/0001193125-26-336843","accession_number":"0001193125-26-336843","importance":35},{"ts":"2026-07-27","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — ALX ONCOLOGY HOLDINGS INC — 2026-07-27","url_slug":"/sec/cik-0001810182/schedule-13g/0002012383-26-002155","accession_number":"0002012383-26-002155","importance":55},{"ts":"2026-07-01","kind":"sec.insider.s","reporter":"Wong Shelly","title":"SVP, FINANCE AND CAO","shares":1404,"price_per_share":2.04,"usd_value":2864,"security_title":"Common Stock","importance":35.00286416},{"ts":"2026-06-30","kind":"sec.filing","form_type":"8-K","title":"8-K — ALX ONCOLOGY HOLDINGS INC — 2026-06-30","url_slug":"/sec/cik-0001810182/8-k/0001193125-26-290447","accession_number":"0001193125-26-290447","importance":35},{"ts":"2026-06-11","kind":"sec.filing","form_type":"8-K","title":"8-K — ALX ONCOLOGY HOLDINGS INC — 2026-06-11","url_slug":"/sec/cik-0001810182/8-k/0001193125-26-267472","accession_number":"0001193125-26-267472","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — Redmile Group, LLC — 2026-05-15","url_slug":"/sec/cik-0001425738/schedule-13g-a/0001104659-26-062566","accession_number":"0001104659-26-062566","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"10-Q","title":"10-Q — ALX ONCOLOGY HOLDINGS INC — 2026-05-08","url_slug":"/sec/cik-0001810182/10-q/0001193125-26-213399","accession_number":"0001193125-26-213399","importance":45},{"ts":"2026-05-08","kind":"sec.filing","form_type":"8-K","title":"8-K — ALX ONCOLOGY HOLDINGS INC — 2026-05-08","url_slug":"/sec/cik-0001810182/8-k/0001193125-26-213380","accession_number":"0001193125-26-213380","importance":35}]}